AIM
MED icon

Advantage Investment Management’s Medifast MED Stock Holding History

Advantage Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$88K Hold
849
– – 0.07% 248
2019
Q2 		$109K Sell
849
-68
-7% -$9.45K 0.08% 223
2019
Q1 		$117K Hold
917
– – 0.09% 214
2018
Q4 		$115K Hold
917
– – 0.09% 211
2018
Q3 		$203K Buy
+917
New +$186K 0.13% 130

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Advantage Investment Management's MED Position: Q3 2019 in Review

Advantage Investment Management held its Medifast (MED) position steady in Q3 2019 at 849 shares worth $88K. The position accounts for 0.07% of the portfolio, ranked #248.

Advantage Investment Management first reported a position in MED in Q3 2018 and has held it in 5 quarters since. The position peaked at $203K in Q3 2018. 239 funds tracked by Wall St. Rank hold MED as of Q3 2019.

  • Advantage Investment Management held 849 shares of Medifast worth $88K as of Q3 2019.
  • Advantage Investment Management left its Medifast share count unchanged in Q3 2019.
  • Medifast made up 0.07% of Advantage Investment Management's portfolio in Q3 2019, its #248 holding.
  • Advantage Investment Management first reported a position in Medifast in Q3 2018 and has held it in 5 quarters since.
  • Advantage Investment Management's Medifast position peaked at $203K in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Medifast as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.